PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 792 participants.
Also called NCT05387954
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 792 participants
- Sponsor
- Registry
-
NCT05387954
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Recruiting
Technical summary
Registry record NCT05387954. Randomized; single masking; primary purpose prevention. Start 2023-07-07 (actual); primary completion 2031-07-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
- Acronym
- CLOSE-2
- Condition
- Cryptogenic Ischemic Stroke
- Condition
- Patent Foramen Ovale
- Intervention (Procedure)
- Transcatheter PFO closure
- Intervention (Drug)
- Oral Anticoagulant, Direct-Acting
- Intervention (Drug)
- Antiplatelet therapy
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Collaborator
- Ministry of Health, France
- Collaborator
- W.L.Gore & Associates
- Collaborator
- Abbott
- Collaborator
- Occlutech International AB
- Collaborator
- Centre Hospitalier St Anne
Record details
- Record id
cardio:ct-nct05387954- Content hash
cf113a509b018d031c03871bc7502da3d9482df4ec1cbce134d9730d3ebdc0de